Authors: | Stopsack, K. H.; Mucci, L. A.; Antonarakis, E. S.; Nelson, P. S.; Kantoff, P. W. |
Title: | TMPRSS2 and COVID-19: Serendipity or opportunity for intervention? |
Abstract: | TMPRSS2 is both the most frequently altered gene in primary prostate cancer and a critical factor enabling cellular infection by coronaviruses, including SARS-CoV-2. The modulation of its expression by sex steroids could contribute to the male predominance of severe infections, and given that TMPRSS2 has no known indispensable functions, and inhibitors are available, it is an appealing target for prevention or treatment of respiratory viral infections. © 2020 American Association for Cancer Research. |
Keywords: | genetics; mortality; genetic predisposition to disease; drug effect; pathology; prostatic neoplasms; gene expression regulation; serine proteinase; serine endopeptidases; prostate tumor; serine proteinase inhibitor; genetic predisposition; influenza; virus pneumonia; influenza, human; serine proteinase inhibitors; pandemic; pneumonia, viral; humans; human; male; female; coronavirus infections; betacoronavirus; coronavirus infection; pandemics; camostat; gabexate; tmprss2 protein, human |
Journal Title: | Cancer Discovery |
Volume: | 10 |
Issue: | 6 |
ISSN: | 2159-8274 |
Publisher: | American Association for Cancer Research |
Date Published: | 2020-06-01 |
Start Page: | 779 |
End Page: | 782 |
Language: | English |
DOI: | 10.1158/2159-8290.Cd-20-0451 |
PUBMED: | 32276929 |
PROVIDER: | scopus |
PMCID: | PMC7437472 |
DOI/URL: | |
Notes: | Article -- Export Date: 1 July 2020 -- Source: Scopus |